These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22829083)

  • 1. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients].
    Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J
    Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does dietary DHA improve neural function in children? Observations in phenylketonuria.
    Koletzko B; Beblo S; Demmelmair H; Müller-Felber W; Hanebutt FL
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):159-64. PubMed ID: 19615874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower n-3 long-chain polyunsaturated fatty acid values in patients with phenylketonuria: a systematic review and meta-analysis.
    Lohner S; Fekete K; Decsi T
    Nutr Res; 2013 Jul; 33(7):513-20. PubMed ID: 23827125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Plasma Docosahexaenoic Acid Levels and Their Relationship to Neurological and Cognitive Functions in PKU Patients: A Double Blind Randomized Supplementation Study.
    Demmelmair H; MacDonald A; Kotzaeridou U; Burgard P; Gonzalez-Lamuno D; Verduci E; Ersoy M; Gokcay G; Alyanak B; Reischl E; Müller-Felber W; Faber FL; Handel U; Paci S; Koletzko B
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30544518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU).
    Koletzko B; Beblo S; Demmelmair H; Hanebutt FL
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48 Suppl 1():S2-7. PubMed ID: 19214054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of LC-PUFA Supplementation in Patients with Phenylketonuria: A Systematic Review of Controlled Trials.
    Couce ML; de Castro MJ; de Lamas C; Leis R
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin.
    Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Moreno J; Tondo M; Artuch R; Campistol J
    Clin Biochem; 2010 Mar; 43(4-5):411-5. PubMed ID: 19948162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU.
    Jans JJ; de Sain-van der Velden MG; van Hasselt PM; van den Hurk DT; Vaz FM; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013 Jun; 109(2):121-4. PubMed ID: 23562298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
    Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
    Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria.
    Beblo S; Reinhardt H; Demmelmair H; Muntau AC; Koletzko B
    J Pediatr; 2007 May; 150(5):479-84. PubMed ID: 17452220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of essential fatty acid supplementation in phenylketonuria.
    Cleary MA; Feillet F; White FJ; Vidailhet M; Macdonald A; Grimsley A; Maurin N; de Baulny HO; Rutherford PJ
    Eur J Clin Nutr; 2006 Jul; 60(7):915-20. PubMed ID: 16523206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants.
    Birch EE; Hoffman DR; Uauy R; Birch DG; Prestidge C
    Pediatr Res; 1998 Aug; 44(2):201-9. PubMed ID: 9702915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid-enriched egg consumption induces accretion of arachidonic acid in erythrocytes of elderly patients.
    Payet M; Esmail MH; Polichetti E; Le Brun G; Adjemout L; Donnarel G; Portugal H; Pieroni G
    Br J Nutr; 2004 May; 91(5):789-96. PubMed ID: 15137931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria.
    Agostoni C; Harvie A; McCulloch DL; Demellweek C; Cockburn F; Giovannini M; Murray G; Harkness RA; Riva E
    Dev Med Child Neurol; 2006 Mar; 48(3):207-12. PubMed ID: 16483397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial.
    Hoffman DR; Birch EE; Castañeda YS; Fawcett SL; Wheaton DH; Birch DG; Uauy R
    J Pediatr; 2003 Jun; 142(6):669-77. PubMed ID: 12838196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria.
    Infante JP; Huszagh VA
    Mol Genet Metab; 2001 Mar; 72(3):185-98. PubMed ID: 11243724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.